Skip to content

Non-Pharmacological Factors on Spinal Block Duration

Analysis of Non-pharmacological Factors on Spinal Anaesthesia Block Duration

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07638280
Enrollment
140
Registered
2026-06-10
Start date
2026-06-16
Completion date
2026-12-16
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paraspinal Muscle Mass and Spinal Anaesthesia

Keywords

anaesthesia, spinal anaesthesia, ultrasound

Brief summary

The aim of this study is to evaluate the effects of non-pharmacological factors-such as age, sex, body mass index, paraspinal muscle mass, vertebral canal anatomy, patient positioning, and injection technique-on the duration of sensory and motor block in patients undergoing spinal anesthesia, and to investigate the potential relationships between these factors and block duration.

Detailed description

It is well known that the level of sensory and motor block following spinal anesthesia varies among individuals. This variability is not only related to the dose of local anesthetic but has also been reported to be associated with patient-related non-pharmacological factors. In particular, a relationship has been demonstrated between body mass index (BMI) and both the level and duration of spinal block, with higher block levels and prolonged block duration observed in patients with increased BMI. This phenomenon is thought to be associated with epidural venous distension due to increased intra-abdominal pressure and a reduction in subarachnoid cerebrospinal fluid (CSF) volume. A decrease in CSF volume may facilitate greater cephalad spread of intrathecal local anesthetic agents, thereby prolonging block duration. Paraspinal muscle mass is also an important anatomical parameter that may influence intra-abdominal pressure and epidural space compliance, and thus may play a determining role in the spread of spinal anesthesia. However, although several studies have investigated the relationship between BMI and body composition and spinal block characteristics, the number of clinical studies directly evaluating the association between ultrasonographically measured paraspinal muscle mass and spinal anesthesia block duration remains limited. Therefore, ultrasonographic measurement of paraspinal muscle thickness may serve as a potential predictor of spinal block duration.

Interventions

PROCEDUREspinal anaesthesia

Patients who will undergo surgery required spinal anaesthesia

Sponsors

Taksim Egitim ve Arastirma Hastanesi
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18-80 years * ASA physical status I-III * Patients scheduled for elective lower abdominal surgery.

Exclusion criteria

* Patient refusal to participate * Coagulopathy * Use of medications or substances known to impair coagulation * Pregnancy, sepsis * Shock * Severe aortic or mitral regurgitation * Peripheral vascular disease * Increased intracranial pressure * Mental disorders * Spinal column deformity * History of previous spinal surgery.

Design outcomes

Primary

MeasureTime frameDescription
Paraspinal mass measurement with ultrasound.Pre-operativeUltrasonographic measurement of paraspinal muscle thickness (cm) and its association with duration of spinal block will be investigated.

Secondary

MeasureTime frameDescription
The spread of the spinal blockPerioperative/PeriproceduralThe speed of the sensational block will be measured after spinal anaesthesia performed. Time(minute) will be recorded when T10 level sensational block is achieved.

Countries

Turkey (Türkiye)

Contacts

CONTACTLeyla Sivacigil, MD
veralleyla@hotmail.com905065983478
CONTACTGuray Demir, Proffesor
guraydemir@gmail.com90 5052113989
PRINCIPAL_INVESTIGATORLeyla Sivacigil

Taksim Training and Research Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026